Project Manager

Costa Rica

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Clinical Research, HealthcareIndustries

Requirements

Candidates should possess a Bachelor's degree and/or proven Project Management skills or industry experience, along with 1-4 years of project management experience in the pharmaceutical or related field. A strong understanding of the drug development process, excellent organizational, interpersonal, time management, and prioritization skills, and proficiency in Microsoft Office are required. The role also necessitates excellent verbal and written communication skills in English, a detail-oriented approach, responsiveness to inquiries, a valid passport, and the ability to travel approximately 20%. Clario PM Certification is required as applicable per the Line of Business.

Responsibilities

The Project Manager will lead the planning, setup, monitoring, and closeout phases of study management, which includes gathering customer requirements, developing study documentation, distributing and tracking equipment, creating and distributing reports, and archiving study data. They will manage study timelines and financial components, including budget reviews, revenue forecasting, scope changes, and invoice reconciliation. The role involves identifying potential study risks and mitigations, escalating issues as appropriate, and managing internal/external negotiations to foster collaboration and efficient resource use. Additionally, the Project Manager will apply problem-solving strategies to address customer issues, maintain issue tracking documentation, ensure timely resolution of escalations, complete timely training, present study services at meetings, attend client meetings to present company services, and assist with training new team members.

Skills

Project Management

Clinical Research

eClinical Solutions

Data Management

Imaging Review

Decentralized Clinical Trials

Oncology

Neuroscience

Cardiac Safety

Customer Requirements Gathering

Study Documentation

Equipment Tracking

Reporting

Data Archiving

Budget Management

Revenue Forecasting

Scope Change Management

Invoice Reconciliation

Risk Management

Negotiation

Collaboration

Problem Solving

Issue Tracking

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free